Furthermore, the concept of targeting ferroptosis is supported by evidence of iron dyshomeostasis, altered system Xc− dynamics (diminished GSH/GPX4 activity) and enhanced lipid peroxidation in AD (Ashraf et al., 2020; Figure 1). This evidence concerns the gene GPX4 and Alzheimer disease.